How much is Plexium worth in 2026?

Plexium has a current valuation of $200.0M based on their Later Stage VC round and secondary market data.

How much funding has Plexium raised?

Plexium has raised $225.1M in total funding across 1 funding rounds.

Plexium

Drug DiscoveryWebsite

Plexium valuation and funding history | Last updated: August 25, 2025 | 1 funding rounds

Current Valuation

$200.0M

As of August 25, 2025

Total Funding Raised

$225.1M

Across 1 round

Last Round

Later Stage VC

$60.1M

Last Funding

Aug 2025

Funding date

Capital Efficiency

0.89x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 28, 2022	Later Stage VC (Series B)	$102.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Plexium is currently valued at $200.0M as of August 25, 2025. The company has raised a total of $225.1M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 0.89x, Plexium has achieved a valuation that is 0.89 times the total capital raised.

Track Plexium Valuation Updates

Get notified when Plexium raises new funding or valuation changes

Explore More Data

Detailed analysis for Plexium

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Plexium's valuation history, funding rounds, and growth metrics.

No credit card required

What is Plexium Worth in 2026?

Plexium is a leading private company in the Drug Discovery sector. Track Plexium's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Plexium Valuation is Determined

Private company valuations like Plexium's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.